| The risk of adverse events of special interest and acute diabetic complications were not increased after coronavirus disease 2019 (COVID-19) vaccination. |
| The benefits of COVID-19 vaccination in type 2 diabetes mellitus (T2DM) patients outweigh its potential risks since T2DM was associated with severe adverse outcomes and mortality in COVID-19. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.